Biopharmaceutical Research Company.
Education about access to innovative therapies, especially in sickle cell disease.

H.R.2113: Prescription Drug STAR Act. Access to innovative therapies in the Medicaid program.

S.2543: Prescription Drug Pricing Reduction Act of 2019.

H.R.3: Lower Drug Costs Now Act of 2019.  

H.R.19: Lower Costs, More Cures Act of 2019.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX